In the second trial, benzalkonium chloride (“BAC”) was instilled in mice eyes over a multiday period to create a model of dry eye disease (the study was repeated twice). BAC is a detergent that ...
Channel Therapeutics Corporation (NYSE:CHRO) announced on Wednesday that it has achieved its predefined endpoints in two preclinical animal models for eye drop formulations (CT2000) for acute ocular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results